WONDFO BIOTECH
Booth 43
About
Founded in 1992, headquartered in Guangzhou science city, Wondfo focuses on the R&D, manufacturing, sales and service of POCT (Point-of-care testing) industry, providing professional rapid diagnosis and chronic disease management solutions.
Wondfo has 8 technology platforms. Our rapid diagnostic devices and reagents cover a wide range, including cardiovascular diseases, diabetes, renal functions, respiratory, fertility, DOA, infections, tumor etc. Our products have been distributed to over 140 countries and regions.
In 2015,Wondfo was listed on Shenzhen Stock Exchange, becoming the first public POCT company in China.Nowadays, Wondfo has 610+ registered trademarks 420+ valid patents and 280+ CE certificates.
Wondfo has 8 technology platforms. Our rapid diagnostic devices and reagents cover a wide range, including cardiovascular diseases, diabetes, renal functions, respiratory, fertility, DOA, infections, tumor etc. Our products have been distributed to over 140 countries and regions.
In 2015,Wondfo was listed on Shenzhen Stock Exchange, becoming the first public POCT company in China.Nowadays, Wondfo has 610+ registered trademarks 420+ valid patents and 280+ CE certificates.
